| Q41993208 | Asthma and lower respiratory symptoms in New York State employees who responded to the World Trade Center disaster |
| Q28384784 | Biomonitoring in California firefighters: metals and perfluorinated chemicals |
| Q46002896 | Biomonitoring perfluorinated compounds in Catalonia, Spain: concentrations and trends in human liver and milk samples. |
| Q77791728 | Cord blood perfluoroalkyl substances in mothers exposed to the World Trade Center disaster during pregnancy |
| Q36926999 | Critical role of PPAR-alpha in perfluorooctanoic acid- and perfluorodecanoic acid-induced downregulation of Oatp uptake transporters in mouse livers |
| Q38211816 | Human biomonitoring of emerging pollutants through non-invasive matrices: state of the art and future potential |
| Q35927643 | Lessons learned from the september 11th disaster: a state health agency perspective |
| Q36095017 | Longitudinal measures of perfluoroalkyl substances (PFAS) in serum of Gullah African Americans in South Carolina: 2003-2013. |
| Q93018646 | Making the invisible visible: results of a community-led health survey following PFAS contamination of drinking water in Merrimack, New Hampshire |
| Q47806217 | Occupational exposure to perfluoroalkyl substances and serum levels of perfluorooctanesulfonic acid (PFOS) and perfluorooctanoic acid (PFOA) in an aging population from upstate New York: a retrospective cohort study |
| Q41612522 | Perfluorodecanoic acid (PFDA) promotes gastric cell proliferation via sPLA2-IIA |
| Q37734611 | Perfluorodecanoic acid stimulates NLRP3 inflammasome assembly in gastric cells |
| Q62086877 | Risk to human health related to the presence of perfluorooctane sulfonic acid and perfluorooctanoic acid in food |
| Q41571384 | Serum perfluoroalkyl substances and cardiometabolic consequences in adolescents exposed to the World Trade Center disaster and a matched comparison group |
| Q28950531 | Serum perfluoroalkyl substances in children exposed to the World Trade Center disaster |